127 related articles for article (PubMed ID: 1886930)
1. Dosimetry of 106Ru eye applicators with a p-type silicon detector.
Lax I
Phys Med Biol; 1991 Jul; 36(7):963-72. PubMed ID: 1886930
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo calculation of the dose distributions of two 106Ru eye applicators.
Sánchez-Reyes A; Tello JI; Guix B; Salvat F
Radiother Oncol; 1998 Nov; 49(2):191-6. PubMed ID: 10052886
[TBL] [Abstract][Full Text] [Related]
3. Results and implications of high-resolution surface dosimetry of ruthenium-106 eye applicators.
Menapace R; Binder W; Chiari A
Ophthalmologica; 1992; 204(2):93-100. PubMed ID: 1594188
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry of ruthenium-106 eye applicators.
Davelaar J; Schaling DF; Hennen LA; Broerse JJ
Med Phys; 1992; 19(3):691-4. PubMed ID: 1508109
[TBL] [Abstract][Full Text] [Related]
5. [Plexiglass replicas for optimizing selection and site of ruthenium 106 applicators].
Menapace R
Klin Monbl Augenheilkd; 1990 Jan; 196(1):40-2. PubMed ID: 2313993
[TBL] [Abstract][Full Text] [Related]
6. [Therapy relevant weak sites in industrial quality assurance of 106Ru eye plaques].
Kaulich TW; Zurheide J; Flühs D; Haug T; Nüsslin F; Bamberg M
Strahlenther Onkol; 2001 Nov; 177(11):616-23; discussion 624-7. PubMed ID: 11757185
[TBL] [Abstract][Full Text] [Related]
7. Comment on Monte Carlo calculation of the dose distributions of two ¹⁰⁶Ru eye applicators [Radiother Oncol 49 (1998) 191-196].
Brualla L; Sempau J; Sauerwein W
Radiother Oncol; 2012 Aug; 104(2):267-8. PubMed ID: 22857802
[No Abstract] [Full Text] [Related]
8. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma.
Wilson MW; Hungerford JL
Ophthalmology; 1999 Aug; 106(8):1579-87. PubMed ID: 10442907
[TBL] [Abstract][Full Text] [Related]
9. Histopathology studies in human malignant melanomas of the choroid after unsuccessful treatment with 106Ru/106Rh ophthalmic applicators.
Klaus H; Lommatzsch PK; Fuchs U
Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):480-6. PubMed ID: 1937083
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium applicators in the treatment of choroidal melanomas.
Van Hijfte R; Verbraeken H; De Laey JJ
Bull Soc Belge Ophtalmol; 1987; 224():51-8. PubMed ID: 3509023
[No Abstract] [Full Text] [Related]
11. Clinical quality assurance for 106Ru ophthalmic applicators.
Kaulich TW; Zurheide J; Haug T; Nüsslin F; Bamberg M
Radiother Oncol; 2005 Jul; 76(1):86-92. PubMed ID: 15972240
[TBL] [Abstract][Full Text] [Related]
12. Fluorescein angiography in the follow-up study of choroidal melanoma after 106Ru/106Rh plaque therapy.
Lommatzsch PK; Ballin RE; Helm W
Retina; 1987; 7(3):148-55. PubMed ID: 3423430
[TBL] [Abstract][Full Text] [Related]
13. [Dosimetry of ruthenium applicators with an eye phantom and small volume thermoluminescence detectors].
Muskalla K; Pothmann B; Alberti W; Bornfeld N; Foerster MH; Harder D; Hermann KP; Tabor P; Sack H; Wessing A
Fortschr Ophthalmol; 1989; 86(6):655-8. PubMed ID: 2625294
[TBL] [Abstract][Full Text] [Related]
14. Does escalation of the apical dose change treatment outcome in beta-radiation of posterior choroidal melanomas with 106Ru plaques?
Hermann RM; Pradier O; Lauritzen K; Ott M; Schmidberger H; Hess CF
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1360-6. PubMed ID: 11955750
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of various malignant melanomas of the choroid using a combination of ruthenium 106 and cobalt 60].
Bacin F; Rozan R; Donnarieix D; Dalens H
Ophtalmologie; 1990; 4(3):225-8. PubMed ID: 2250952
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanomas of the choroid and ruthenium applicators.
Huyghe JP; Verbraeken H; Goes F; De Wilde G; Hanssens M; Brabant P; Van Hijfte R; De Laey JJ
Bull Soc Belge Ophtalmol; 1990; 238():137-43. PubMed ID: 2131116
[TBL] [Abstract][Full Text] [Related]
17. Ru106 brachytherapy for management of choroidal melanoma: do we need to adjust total dose according to the new NIST calibration measurement?
Lotayef MM; Othman IS; Shelil AE; Kerima H
J Egypt Natl Canc Inst; 2005 Sep; 17(3):211-7. PubMed ID: 16799659
[TBL] [Abstract][Full Text] [Related]
18. [Optimization of irradiation time in the treatment of malignant melanoma of the choroid with beta applicators (106Ru/106Rh)].
Lommatzsch PK; Weise B; Ballin R
Klin Monbl Augenheilkd; 1986 Aug; 189(2):133-40. PubMed ID: 3761990
[TBL] [Abstract][Full Text] [Related]
19. Local tumor control after 106Ru brachytherapy of choroidal melanoma.
Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):385-91. PubMed ID: 15913907
[TBL] [Abstract][Full Text] [Related]
20. Development of a high precision dosimetry system for the measurement of surface dose rate distribution for eye applicators.
Eichmann M; Flühs D; Spaan B
Med Phys; 2009 Oct; 36(10):4634-43. PubMed ID: 19928095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
